BRUSSELS/LONDON Anheuser-Busch InBev , the world's largest brewer, is selling its Australian operations to Japan's Asahi for $11 billion and could revive the stalled flotation of its Asian business as it looks to cut debt.
LONDON/FRANKFURT British fund manager Neil Woodford is looking to kick off the sale of his unlisted biotech investments at the end of July, but faces months of negotiations to offload the portfolio, a source familiar with the matter told Reuters.
FRANKFURT/LONDON Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the $59 billion purchase of Shire, sources close to the matter told Reuters.
LONDON The Competition and Markets Authority (CMA) said on Tuesday it was looking into whether the proposed acquisition of Britain's largest satellite company Inmarsat by a private equity-led consortium would affect the competitive landscape.
FRANKFURT/LONDON Swiss Re is considering postponing or restructuring the $4.1 billion London listing of its UK life insurance business due to limited investor appetite, sources familiar with the matter said on Wednesday.
FRANKFURT/LONDON Bayer has approached U.S. drug firm Elanco Animal Health to discuss a possible combination of their pet-health businesses to create an industry giant, three sources familiar with the matter told Reuters.
LISBON/LONDON Italy's Generali has entered exclusive negotiations to buy Portuguese insurer Tranquilidade in a deal to boost its presence in Portugal, two sources familiar with the matter said.